ANPMF Insider Trading Activity and SEC Form 4 Filings
ANPMF insider trading summary
No open-market insider purchases or sales of Angiotech Pharmaceuticals Inc (ANPMF) have been reported on SEC Form 4 in the past 12 months.
Latest ANPMF insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 21, 2012 | Highland Crusader Offshore Partners, L.P. | 10% Owner | Sell | $17.2M (1,115,000 @ $15.43) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.